Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Public ClinicalTrials.gov record NCT06005610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Giving Standardized Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Study identification
- NCT ID
- NCT06005610
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Interventions
- Estradiol Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 3, 2024
- Primary completion
- Aug 20, 2025
- Completion
- Aug 20, 2025
- Last update posted
- Apr 7, 2026
2024 – 2025
United States locations
- U.S. sites
- 14
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCSD Antiviral Research Center CRS (701) | San Diego | California | 92103 | — |
| University of California, San Francisco HIV/AIDS CRS (801) | San Francisco | California | 94110 | — |
| University of Colorado Hospital CRS (6101) | Aurora | Colorado | 80045 | — |
| Whitman-Walker Institute, Inc. CRS (31791) | Washington D.C. | District of Columbia | 20005 | — |
| The Ponce de Leon Center CRS (5802) | Atlanta | Georgia | 30308 | — |
| Johns Hopkins University CRS (201) | Baltimore | Maryland | 21205 | — |
| Washington University Therapeutics (WT) CRS (2101) | St Louis | Missouri | 63110-1010 | — |
| New Jersey Medical School Clinical Research Center CRS (31786) | Newark | New Jersey | 07103 | — |
| Weill Cornell Uptown CRS (site 7803) | New York | New York | 10065 | — |
| Chapel Hill CRS (3201) | Chapel Hill | North Carolina | 27599-7215 | — |
| Greensboro CRS (3203) | Greensboro | North Carolina | 27401 | — |
| Case CRS (2501) | Cleveland | Ohio | 44106 | — |
| Vanderbilt Therapeutics CRS (3652) | Nashville | Tennessee | 37204 | — |
| Houston AIDS Research Team CRS (31473) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06005610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06005610 live on ClinicalTrials.gov.